Afrigen

From Wikipedia, the free encyclopedia

Afrigen Biologics and Vaccines is a South African pharmaceutical company. Afrigen developed a COVID vaccine and is working on mRNA vaccines for tuberculosis and HIV.[1][2][3] It is based in the City of Cape Town Metropolitan Municipality.[4]

References[edit]

  1. ^ Dutton, Jack (26 October 2022). "First African-made mRNA vaccine, a test platform for the future". Nature Africa. doi:10.1038/d44148-022-00151-3.
  2. ^ Barry-Jester, Anna Maria (4 October 2023). "How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits". ProPublica. Retrieved 19 November 2023.
  3. ^ Aizenman, Nurith (28 December 2022). "How a scrappy African startup could forever change the world of vaccines". NPR. Retrieved 19 November 2023.
  4. ^ Aizenman, Nurith (28 December 2022). "How a scrappy African startup could forever change the world of vaccines". NPR. Retrieved 19 November 2023.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Afrigen&oldid=1223392624"